Niagen Bioscience Inc
(FRA:OCD1)
€
2.6
+0.22 (+9.24%)
Market Cap: 206.17 Mil
Enterprise Value: 150.04 Mil
PE Ratio: 19.10
PB Ratio: 3.29
GF Score: 68/100 Sorry the transcript is not found. Please try another one.